Recently added
This page was added on 04 June 2018.
Updates made
This page was updated on [date-counter-updated-date]. View history of updates
Sponsor
Sanofi-Aventis Australia
Administration route
Intramuscular injection
Subcutaneous injection
Vaccine group
Combination vaccines
Description:
Registered as a booster in people aged ≥10 years.
dTpa — pertussis-acellular combined with diphtheria and tetanus toxoids (Adsorbed) (reduced antigen formulation)
Each 0.5 mL monodose vial or pre-filled syringe contains:
- ≥2 IU Diphtheria toxoid
- ≥20 IU Tetanus toxoid
- 2.5 µg Pertussis toxoid
- 5 µg Filamentous Haemagglutinin
- 3 µg Pertactin
- 5 µg Pertussis fimbriae types 2 and 3
Absorbed on aluminium phosphate.
Also contains traces of:
- phenoxyethanol
- formaldehyde
- glutaral
- bovine derived materials
- latex
Contains traces of latex.
For Product Information and Consumer Medicine Information about Adacel visit the Therapeutic Goods Administration website.
Additional vaccine information
For detailed advice on vaccine dosage, administration, contraindications and precautions, and variations from product information, please visit the relevant disease chapter/s.
Related diseases
Page history
Last updated
Last reviewed